Leo Pharma
ActiveSummary
Leo Pharma has been active since 1967 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €9.9m and a net result of €615,360. Equity is growing by ~5.3% per year across the filed fiscal years. Its solvency ranks better than 72% of 5048 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
This company filed its last 7 accounts on average 40 days before the deadline; the sector median for financial year 2024 is 3 days before the deadline, and 39% of the sector filed late.
Checked, nothing found (2)
History
Leo Pharma was incorporated on 1 April 1967.1 The registered office was moved to Lier in 2010.2 The board currently has 2 members; Hilda De Swaef has served longest, since 2012.3 Revenue grew from EUR 27 million in 2018 to EUR 32 million in 2025 and headcount from 30.9 to 21.7 full-time equivalents.4
Go further with this company
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, full schema
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 46, Wholesale trade, each year against the same schema; no band under 30 filings. Dashed line: the median.
Peer companies
Historical observationOf the 14,732 companies that looked in July 2024 the way this one looks now, 0.2% went bankrupt within 24 months and 96% are still going.
- Small
- 20 years or older
- solvency 30% or more
- a profit under 5% of the balance sheet
A further 0.1% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a bankruptcy probability of 0.2% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,338 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 1.0% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.9% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 14,732 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Operating income70/76A | €27.2m | €29.0m | €34.6m | €33.9m | €32.3m | ▼ 4.7% |
| Turnover70 | €27.2m | €27.0m | €33.1m | €33.9m | €32.1m | ▼ 5.4% |
| Other operating income74 | €0 | €2.0m | €1.6m | €9,859 | €256,163 | ▲ 2,498% |
| Operating charges60/66A | €26.5m | €28.9m | €33.7m | €33.1m | €31.5m | ▼ 4.7% |
| Goods for resale, raw materials and consumables60 | €17.4m | €17.6m | €21.9m | €19.0m | €18.7m | ▼ 1.8% |
| Purchases600/8 | €17.8m | €17.7m | €22.0m | €19.6m | €17.4m | ▼ 11.1% |
| Change in stocks: decrease (increase)609 | -€422,593 | -€83,931 | -€80,737 | -€577,789 | €1.3m | ▲ 317% |
| Services and other goods61 | €3.3m | €4.3m | €3.2m | €3.4m | €3.5m | ▲ 3.0% |
| Remuneration, social security and pensions62 | €4.4m | €5.4m | €4.9m | €4.9m | €3.8m | ▼ 23.1% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €44,919 | €50,357 | €32,746 | €21,064 | €16,348 | ▼ 22.4% |
| Provisions for liabilities and charges: additions (uses and reversals)635/8 | -€200,000 | €0 | - | - | - | - |
| Other operating charges640/8 | €1.6m | €1.6m | €3.6m | €5.7m | €5.5m | ▼ 2.7% |
| Operating profit (loss)9901 | €664,563 | €84,902 | €974,049 | €845,935 | €798,745 | ▼ 5.6% |
| Financial income75/76B | €40,014 | €9,897 | €211,613 | €160,318 | €115,470 | ▼ 28.0% |
| Recurring financial income75 | €40,014 | €9,897 | €211,613 | €160,318 | €115,470 | ▼ 28.0% |
| Income from current assets751 | - | €9,897 | €211,302 | €159,401 | €115,065 | ▼ 27.8% |
| Other financial income752/9 | €40,014 | €0 | €312 | €918 | €404 | ▼ 55.9% |
| Financial charges65/66B | €3,873 | €15,021 | €4,535 | €9,247 | €5,384 | ▼ 41.8% |
| Recurring financial charges65 | €3,873 | €15,021 | €4,535 | €9,247 | €5,384 | ▼ 41.8% |
| Debt charges650 | €771 | €14,210 | €0 | - | €488 | - |
| Other financial charges652/9 | €3,103 | €811 | €4,535 | €9,247 | €4,895 | ▼ 47.1% |
| Profit (loss) for the period before taxes9903 | €700,704 | €79,777 | €1.2m | €997,006 | €908,831 | ▼ 8.8% |
| Income taxes67/77 | €287,501 | €247,398 | €387,732 | €312,740 | €293,471 | ▼ 6.2% |
| Taxes670/3 | €287,501 | €282,009 | €387,732 | €312,740 | €293,471 | ▼ 6.2% |
| Tax adjustments and reversals of tax provisions77 | - | €34,612 | €0 | €0 | - | - |
| Profit (loss) for the period9904 | €413,203 | -€167,620 | €793,396 | €684,266 | €615,360 | ▼ 10.1% |
| Profit (loss) for the period to be appropriated9905 | €413,203 | -€167,620 | €793,396 | €684,266 | €615,360 | ▼ 10.1% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €20.7m | €19.1m | €17.5m | €12.1m | €15.1m | ▲ 23.9% |
| Fixed assets21/28 | €228,994 | €178,636 | €145,890 | €151,853 | €145,493 | ▼ 4.2% |
| Intangible fixed assets21 | €102,003 | €93,842 | €85,682 | €77,522 | €69,362 | ▼ 10.5% |
| Tangible fixed assets22/27 | €87,521 | €45,324 | €20,738 | €34,861 | €36,662 | ▲ 5.2% |
| Plant, machinery and equipment23 | €87,521 | €45,324 | €20,738 | €34,861 | €36,662 | ▲ 5.2% |
| Other tangible fixed assets26 | €0 | - | - | - | - | - |
| Financial fixed assets28 | €39,470 | €39,470 | €39,470 | €39,470 | €39,470 | = |
| Other financial fixed assets284/8 | €39,470 | €39,470 | €39,470 | €39,470 | €39,470 | = |
| Amounts receivable and cash guarantees285/8 | €39,470 | €39,470 | €39,470 | €39,470 | €39,470 | = |
| Current assets29/58 | €20.5m | €18.9m | €17.3m | €12.0m | €14.9m | ▲ 24.3% |
| Stocks and contracts in progress3 | €5.3m | €5.3m | €5.4m | €6.0m | €4.7m | ▼ 20.9% |
| Stocks30/36 | €5.3m | €5.3m | €5.4m | €6.0m | €4.7m | ▼ 20.9% |
| Goods purchased for resale34 | €5.3m | €5.3m | €5.4m | €6.0m | €4.7m | ▼ 20.9% |
| Amounts receivable within one year40/41 | €5.6m | €13.6m | €11.9m | €6.0m | €10.1m | ▲ 68.2% |
| Trade receivables40 | €5.1m | €4.5m | €4.5m | €5.2m | €5.0m | ▼ 5.1% |
| Other amounts receivable41 | €537,379 | €9.0m | €7.4m | €761,247 | €5.1m | ▲ 572% |
| Current investments50/53 | €9.6m | €0 | - | - | - | - |
| Other investments51/53 | €9.6m | €0 | - | - | - | - |
| Cash at bank and in hand54/58 | €2,870 | €0 | - | - | - | - |
| Deferred charges and accrued income490/1 | €0 | - | - | - | €80,000 | - |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €20.7m | €19.1m | €17.5m | €12.1m | €15.1m | ▲ 23.9% |
| Equity10/15 | €8.0m | €7.8m | €8.6m | €9.3m | €9.9m | ▲ 6.6% |
| Contributions10/11 | €644,523 | €644,523 | €644,523 | €644,523 | €644,523 | = |
| Capital10 | €272,683 | €272,683 | €272,683 | €272,683 | €272,683 | = |
| Issued capital100 | €272,683 | €272,683 | €272,683 | €272,683 | €272,683 | = |
| Outside capital11 | €371,840 | €371,840 | €371,840 | €371,840 | €371,840 | = |
| Share premium1100/10 | €371,840 | €371,840 | €371,840 | €371,840 | €371,840 | = |
| Reserves13 | €27,268 | €27,268 | €27,268 | €27,268 | €27,268 | = |
| Non-distributable reserves130/1 | €27,268 | €27,268 | €27,268 | €27,268 | €27,268 | = |
| Legal reserve130 | €27,268 | €27,268 | €27,268 | €27,268 | €27,268 | = |
| Profit (loss) carried forward14 | €7.3m | €7.2m | €8.0m | €8.6m | €9.3m | ▲ 7.1% |
| Provisions and deferred taxes16 | €0 | - | - | - | - | - |
| Provisions for liabilities and charges160/5 | €0 | - | - | - | - | - |
| Other liabilities and charges164/5 | €0 | - | - | - | - | - |
| Amounts payable17/49 | €12.7m | €11.2m | €8.8m | €2.8m | €5.1m | ▲ 81.1% |
| Amounts payable within one year42/48 | €12.7m | €11.2m | €8.8m | €2.7m | €5.1m | ▲ 85.8% |
| Trade debts44 | €11.5m | €10.2m | €7.6m | €1.4m | €4.1m | ▲ 184% |
| Suppliers440/4 | €11.5m | €10.2m | €7.6m | €1.4m | €4.1m | ▲ 184% |
| Taxes, remuneration and social security45 | €1.1m | €914,948 | €1.2m | €1.3m | €998,721 | ▼ 22.6% |
| Taxes450/3 | €440,892 | €123,077 | €417,492 | €251,133 | €257,550 | ▲ 2.6% |
| Remuneration and social security454/9 | €668,452 | €791,870 | €760,548 | €1.0m | €741,171 | ▼ 28.7% |
| Other amounts payable47/48 | €0 | - | €1,816 | €1,160 | €1,163 | ▲ 0.3% |
| Accrued charges and deferred income492/3 | €77,971 | €67,199 | €51,211 | €101,818 | €55,486 | ▼ 45.5% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €413,203 | -€167,620 | €793,396 | €684,266 | €615,360 | ▼ 10.1% |
| + Depreciation and write-downs630 | €44,919 | €50,357 | €32,746 | €21,064 | €16,348 | ▼ 22.4% |
| Operating cash flow (approximation) | €458,122 | -€117,263 | €826,142 | €705,331 | €631,707 | ▼ 10.4% |
| Investment in fixed assets (approximation) | - | €0 | €0 | -€27,027 | -€9,988 | ▲ 63.0% |
| Change in cash | - | -€2,870 | - | - | - | - |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
09-06
State Gazette act
Reappointment: DELOITTE Bedrijfsrevisoren (statutory auditor)Permanent representative: Pieter-Jan Jean-Baptiste E Van Durme3 facts ▸
- General meeting, 30-04-2026
- Auditor reappointment, DELOITTE Bedrijfsrevisoren (statutory auditor)
- Permanent representative, Pieter-Jan Jean-Baptiste E Van Durme (permanent vertegenwoordiger)
15-04
State Gazette act
Statutes amendmentPower of attorney4 facts ▸
- General meeting, 11-04-2025
- Statutes amendment
- Power of attorney, Leo Pharma
- Power of attorney, Leo Pharma
11-02
State Gazette act
Appointment: Dilay Kücükkose (director)Resignation: Anders Krüger (director) · Mandate compensation · Director discharge5 facts ▸
- General meeting, 27-01-2025
- Director appointment, Dilay Kücükkose (director)
- Mandate compensation, Dilay Kücükkose
- Director resignation, Anders Krüger (director)
- Director discharge, Anders Krüger
30-01
State Gazette act
Resignations & appointmentsPower of attorney5 facts ▸
- Board meeting, 20-01-2025
- Power of attorney, Philip Van Den Eynden
- Power of attorney, Mariana Vieira Falsca
- Power of attorney, Martine Debecker
- Power of attorney, Antoine Bodereau
06-02
State Gazette act
Resignation: Jannie Holm (director)Appointment: Anders Krüger (director) · Mandate compensation6 facts ▸
- General meeting, 10-01-2024
- Director resignation, Jannie Holm (director)
- Director appointment, Anders Krüger (director)
- Mandate compensation, Anders Krüger
- Board composition, Hilda De Swaef (director)
- Board composition, Anders Krüger (director)
28-06
State Gazette act
Reappointment: Deloitte Bedrijfsrevisoren BV (statutory auditor)Power of attorney5 facts ▸
- Board meeting, 22-05-2023
- Power of attorney, David Wilson
- Power of attorney, Mariana Vieira Faísca
- General meeting, 31-05-2023
- Auditor reappointment, Deloitte Bedrijfsrevisoren BV
Show earlier events
02-09
State Gazette act
Permanent representative: Pieter-Jan Van DurmeAccounting effect · Power of attorney4 facts ▸
- Board meeting, 19-08-2022
- Permanent representative, Pieter-Jan Van Durme
- Accounting effect, 01-01-2021
- Power of attorney, KPMG Law BV
08-08
State Gazette act
Resignations & appointmentsPower of attorney4 facts ▸
- Board meeting, 15-07-2022
- Power of attorney, Lucy Megens
- Power of attorney, David Wilson
- Power of attorney, Philip Van den Eynden
30-03
State Gazette act
Resignation: Michael Grue (director)Appointments: Jannie Holm (director) and Hilda De Swaef (director) · Director discharge · Mandate compensation11 facts ▸
- General meeting, 17-03-2022
- Director resignation, Michael Grue (director)
- Director discharge, Michael Grue
- Director appointment, Jannie Holm (director)
- Director appointment, Hilda De Swaef (director)
- Mandate compensation, Jannie Holm
- Mandate compensation, Hilda De Swaef
- Board composition, Jannie Holm (director)
- Board composition, Hilda De Swaef (director)
- Director appointment, Hilda De Swaef (managing director)
- Governance structure, de Vennootschap opnieuw door een raad van bestuur zal worden bestuurd
05-01
State Gazette act
Resignation: Catherine Mazzacco (director)Director discharge · Statutes amendment · Power of attorney6 facts ▸
- General meeting, 20-12-2021
- Director resignation, Catherine Mazzacco (director)
- Director discharge, Catherine Mazzacco
- Board composition, Michael Grue (director)
- Statutes amendment
- Power of attorney, KPMG Law BV
03-08
State Gazette act
Reappointment: Deloitte Bedrijfsrevisoren CV (statutory auditor)Permanent representative: Gert Vanhees · Resignations: Kim Kjøller (director) and Anders Kronborg (director) · Appointment: Michael Grue (director)10 facts ▸
- General meeting, 30-06-2020
- Auditor reappointment, Deloitte Bedrijfsrevisoren CV
- Permanent representative, Gert Vanhees
- General meeting, 06-07-2021
- Director resignation, Kim Kjøller (director)
- Director resignation, Anders Kronborg (director)
- Director appointment, Michael Grue (director)
- Mandate compensation, Michael Grue
- Board composition, Michael Grue (director)
- Board composition, Catherine Thérése Jeanne Mazzacco (director)
25-11
State Gazette act
BoekjaarPurpose change · Statutes amendment · Capital7 facts ▸
- General meeting, 20-10-2020
- Purpose change, Uitbreiding van het voorwerp met: "De vennootschap heeft eveneens als voorwerp de controle van het bestuur of de deelneming aan het bestuur van elke onderneming…
- Statutes amendment
- Statutes amendment
- Capital, €272.682,87
- Statutes amendment
- Governance, Bevestiging dat de vennootschap wordt bestuurd door een raad van bestuur; geen wijzigingen aan de mandaten.
29-09
State Gazette act
Resignation: De Swaef (director)Appointment: De Swaef (day-to-day manager) · Power of attorney8 facts ▸
- General meeting, 18-08-2020
- Board meeting, 18-08-2020
- Director resignation, De Swaef (director)
- Power of attorney, Michel Bonne
- Power of attorney, Hannelore Matthys
- Power of attorney, Andreas Wuylens
- Power of attorney, Shaziea Habibi
- Director appointment, De Swaef (day-to-day manager)
31-10
State Gazette act
Resignation: Aabo GITTE (director)Appointment: Catherine Thérése Jeanne MAZZACCO (director) · Mandate compensation4 facts ▸
- General meeting, 10-10-2019
- Director resignation, Aabo GITTE (director)
- Director appointment, Catherine Thérése Jeanne MAZZACCO (director)
- Mandate compensation, Catherine Thérése Jeanne MAZZACCO
27-08
State Gazette act
Resignations & appointments · MiscellaneousManagement decision · Power of attorney · Mandate term4 facts ▸
- Management decision, 08-08-2018
- Power of attorney, Lucy Megens
- Mandate term, onbepaalde duur
- Mandate expiry condition, automatische vervaling wanneer mevrouw Megens niet langer werkzaam is voor de Vennootschap
03-01
State Gazette act
Resignation: PricewaterhouseCoopers Bedrijfsrevisoren BCVBA (statutory auditor)Appointment: Deloitte Bedrijfsrevisoren BCVBA (statutory auditor) · Mandate term4 facts ▸
- General meeting, 30-10-2017
- Auditor resignation, PricewaterhouseCoopers Bedrijfsrevisoren BCVBA (statutory auditor)
- Auditor appointment, Deloitte Bedrijfsrevisoren BCVBA (statutory auditor)
- Mandate term, until the general meeting approving the accounts for the fiscal year ending 31 December 2019
28-09
State Gazette act
Resignation: Kristian Merser (director)Appointment: Kim Kjøller (director)3 facts ▸
- General meeting, 01-09-2016
- Director resignation, Kristian Merser (director)
- Director appointment, Kim Kjøller (director)
20-05
State Gazette act
Reappointments: Gitte Aabo (director and chair of the board) and PricewaterhouseCoopers Bedrijfsrevisoren (statutory auditor)Appointments: Kristian Merser (director) and Anders Kronborg (director) · Resignations: Lars Olsen, Lars Enghave Minor and Hilde De Swaef8 facts ▸
- General meeting, 01-04-2016
- Director reappointment, Gitte Aabo (director and chair of the board)
- Director appointment, Kristian Merser (director)
- Director appointment, Anders Kronborg (director)
- Director resignation, Lars Olsen (director)
- Director resignation, Lars Enghave Minor (director)
- Director resignation, Hilde De Swaef (director)
- Auditor reappointment, PricewaterhouseCoopers Bedrijfsrevisoren
27-05
State Gazette act
Reappointment: BCVBA PricewaterhouseCoopers Bedrijfsrevisoren (statutory auditor)Permanent representative: Bart Vari Gompel3 facts ▸
- General meeting, 11-04-2013
- Auditor reappointment, BCVBA PricewaterhouseCoopers Bedrijfsrevisoren
- Permanent representative, Bart Vari Gompel
03-07
State Gazette act
Resignations: Jens Bo Olesen (director) and Tore Waeborg (director)Appointments: Lars Enghave Minor (director) and Hilda de Swaef (director) · Mandate compensation · Power of attorney19 facts ▸
- General meeting, 15-06-2012
- Director resignation, Jens Bo Olesen (director)
- Director resignation, Tore Waeborg (director)
- Director appointment, Lars Enghave Minor (director)
- Director appointment, Hilda de Swaef (director)
- Mandate compensation, Lars Enghave Minor
- Mandate compensation, Hilda de Swaef
- Board composition, Gitte Pugholm Aabo (director)
- Board composition, Lars Olsen (director)
- Board composition, Lars Enghave Minor (director)
- Board composition, Hilda de Swaef (director)
- Power of attorney, Tom Swinnen
- +7 further facts in this act
29-03
State Gazette act
Capital & shares · Statutes amendmentCapital4 facts ▸
- General meeting, 18-01-2011
- Capital, €272.682,87
- Statutes amendment
- Board resolution, 25-02-2010
08-02
State Gazette act
Resignation: BDO Bedrijfsrevisoren BCVBA (statutory auditor)Appointment: PricewaterhouseCoopers Bedrijfsrevisoren (statutory auditor) · Mandate term4 facts ▸
- General meeting, 27-09-2010
- Director resignation, BDO Bedrijfsrevisoren BCVBA (statutory auditor)
- Auditor appointment, PricewaterhouseCoopers Bedrijfsrevisoren (statutory auditor)
- Mandate term, einde onmiddellijk na de gewone algemene vergadering van aandeelhouders te houden in 2013
25-05
State Gazette act
Registered officeRegistered-office move2 facts ▸
- Board meeting, 25-02-2010
- Registered-office move, Duijckstraat 17, 2500 Lier
06-05
State Gazette act
Appointments: Tore Waeborg, Hilde De Swaet and Lars OlsenReappointments: Gitte Aabo, Jens Bo Olesen and 2 others · Resignations: Ger Schoor (director) and Jens Bo Olesen (director)11 facts ▸
- Board meeting, 25-02-2010
- General meeting, 25-02-2010
- Director appointment, Tore Waeborg (managing director)
- Director appointment, Hilde De Swaet (director (executive))
- Director reappointment, Gitte Aabo (director)
- Director reappointment, Jens Bo Olesen (director)
- Director reappointment, Tore Waeborg (director)
- Director reappointment, Ger Schoor (director)
- Director appointment, Lars Olsen (director)
- Director resignation, Ger Schoor (director)
- Director resignation, Jens Bo Olesen (director)
30-12
State Gazette act
Resignation: Ernst Lunding (director)Reappointments: Gitte Aabo, Bo Olesen and 3 others · Permanent representative: Jan Vercauteren · Mandate compensation9 facts ▸
- General meeting, 04-03-2008
- Director resignation, Ernst Lunding (director)
- Director reappointment, Gitte Aabo (director)
- Director reappointment, Bo Olesen (director)
- Director reappointment, Ger Schoor (director)
- Director reappointment, Tore Waeborg (director)
- Mandate compensation, LEO PHARMA
- Auditor reappointment, BDO Bedrijfsrevisoren
- Permanent representative, Jan Vercauteren (company auditor)
04-02
State Gazette act
Reappointments: Ernst Lunding, Jens Bo Olesen and Ger SchoorAppointments: Gitte Aabo (director) and Tore Waeborg (director) · Mandate term · Number of directors12 facts ▸
- General meeting, 06-03-2007
- Director reappointment, Ernst Lunding (director)
- Director reappointment, Jens Bo Olesen (director)
- Director reappointment, Ger Schoor (director)
- Director appointment, Gitte Aabo (director)
- Director appointment, Tore Waeborg (director)
- Mandate term, eindigt onmiddellijk na de jaarvergadering die zal worden gehouden in 2008
- Mandate term, eindigt onmiddellijk na de jaarvergadering die zal worden gehouden in 2008
- Mandate term, eindigt onmiddellijk na de jaarvergadering die zal worden gehouden in 2008
- Mandate term, eindigt onmiddellijk na de jaarvergadering die zal worden gehouden in 2008
- Mandate term, eindigt onmiddellijk na de jaarvergadering die zal worden gehouden in 2008
- Number of directors, 5
Directors · office · real estate
Board 2
3 not recently confirmed
Day-to-day management 1
Statutory auditor 1
Other functions 1
1 establishment unit
1 parcel
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 12392A0300/00C000 | Flanders | 5.6 ha | 1 · 2.3 ha | 20.8 m · 3 fl. |
Linked by address, not proof of ownership
Mandate history
- Board
- Day-to-day management
- Statutory auditor
- Other function
- not recently confirmed
- began earlier
| Name | Functions and periods |
|---|---|
| Hilda De Swaef |
|
| Dilay Kücükkose |
|
| Deloitte Bedrijfsrevisoren |
|
| Ernst Lunding |
|
| Bo Olesen |
|
| Catherine Thérése Jeanne MAZZACCO |
|
| Hilde De Swaet |
|
| Anders Krüger |
|
| Jannie Holm |
|
| Michael Grue |
|
| Catherine Mazzacco |
|
| De Swaef |
|
| Anders Kronborg |
|
| Kim Kjøller |
|
| Aabo GITTE |
|
| PricewaterhouseCoopers, Bedrijfsrevisoren |
|
| Kristian Merser |
|
| Hilde De Swaef |
|
| Lars Enghave Minor |
|
| Lars Olsen |
|
| Jens Bo Olesen |
|
| Tore Waeborg |
|
| BDO Bedrijfsrevisoren |
|
| Ger Schoor |
|
Articles of association
Full purpose
De fabricage, de import en export, alsmede de handel, de makelarij en de commissieverhandeling, zo in het groot als in het half groot en in het klein, van alle farmaceutische producten, de exploitatie van octrooien, merken en licenties, research op wetenschappelijk en op economisch vlak en op marktgebied in verband daarmede, dit alles rechtstreeks en zijdelings, door financiering van andere bedrijven en het nemen van belangen in deze ondernemingen. De vennootschap zal eveneens alle onroerende goederen kunnen huren en verhuren, in concessie en erfpacht mogen geven en nemen. De vennootschap heeft eveneens als voorwerp de controle van het bestuur of de deelneming aan het bestuur van elke onderneming, in voorkomend geval door het uitoefenen van een mandaat, zoals dit van bestuurder, lid van de raad van toezicht of de directieraad. Zij kan ook het mandaat van vereffenaar uitoefenen. De vennootschap kan alle financieringen, zoals leningen, kredieten of gelijkaardige verrichtingen, aangaan en toestaan. De vennootschap kan zekerheden verstrekken, zowel voor haar eigen verbintenissen als voor de verbintenissen van andere groepsvennootschappen, onder andere door haar goederen in hypotheek of in pand te geven, met inbegrip van haar handelsfonds. De vennootschap zal in het algemeen alle commerciële, industriële, financiële, roerende en onroerende handelingen mogen verrichten in rechtstreeks of onrechtstreeks verband met haar voorwerp of die van aard zouden zijn dat zij het bereiken ervan geheel of ten dele vergemakkelijken.
Structure & network
Connections & network
2 current directorsThe network starts from this company’s directors. Other companies they run appear here as nodes.
Capital and shareholders
- 25-11-2020 Capital stated in 2 acts · 272,682.87 EUR · 55,992 shares
Similar companies · same sector, comparable size
Identification & contact
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 29 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.